Dr. Wing Chang is the Director of Research and Development at STEMCELL Technologies, Cambridge, UK. He currently leads the Stem Cell group which is actively developing innovative products for culturing pluripotent stem cells (PSCs), reprogramming somatic cells to induced PSCs (iPSCs), and—more recently—developing reagents for culturing ground state or naïve PSCs. He has been integral in the development of numerous products at STEMCELL Technologies, including TeSR™-E7, ReproTeSR™, and RSeT™. Dr. Chang also serves as an instructor in several of STEMCELL Technologies’ Pluripotent Stem Cell training courses. Dr. Chang received his PhD from the University of Western Ontario, where he studied cell cycle regulatory factors and their role in keratinocyte stem cell self-renewal and differentiation. During his postdoctoral training at the University of Toronto, he examined transcriptional networks in human embryonic stem cells and iPSCs important for stem cell self-renewal and differentiation.
About STEMCELL Technologies
STEMCELL Technologies Inc. is a privately-owned biotechnology company based in Vancouver that helps power leading-edge life science research around the world. Scientists performing stem cell, immunology, cancer, regenerative medicine and cellular therapy research are among those who rely on our cell culture media, cell separation products, instruments, ancillary reagents and contract assay services. We create novel, useful, standardized products of unfailing quality and deliver them to more than 70 countries via our many regional offices plus distribution centres in Vancouver, Seattle, Grenoble and Singapore. Driven by our love of science and our passion for quality, we see ourselves simply as “Scientists Helping Scientists” – standing by our customers to provide outstanding products, technical support and training. We have over 1000 science-oriented employees globally, including 250 PhDs/MScs, with most others holding a BSc or engineering degree. STEMCELL is proud to be the largest Biotechnology employer in Canada.
STEMCELL is continuing to expand its European operations, particularly in the areas of R&D personnel and facilities, manufacturing, quality control, quality assurance and regulatory activities that will meet the highest levels of European research and regular standards. STEMCELL UK Ltd. (STUK) was established in July 2014. In 2016 STUK expanded its capabilities to include research and development (R&D) with staff located in laboratory space in Cambridge, UK, including fully functional laboratory space containing state of the art cell culture and analytical chemistry equipment as well as an ISO 13485-certified manufacturing clean room that is adopting single use technology and closed systems for manufacturing higher compliance media and culture reagents.